Childhood soft tissue tumors, one center experience

Aim: Studies on childhood soft tissue tumors have generally been conducted with malignant tumors. There are few studies in the literature comprising all soft tissue tumors. The current study aimed to examine the incidence of all benign and malignant soft tissue tumors during childhood in East Mediterranean region. Materials and Methods: This study retrospectively analyzed the data gathered from patients diagnosed with soft tissue tumors according to the WHO 2020 classification. It focused on those aged 0–18 years that underwent excisional biopsy at Adana City Training and Research Hospital (Adana, Turkey) between 2014 and 2020. Results: Of the total patients, 47.5% were female and 52.5% male. Of these, 87.2% of the cases were benign, 9.2% malignant, and 3.6% intermediate. Hemangioma (55%) was the most common benign soft tissue tumor, and the most common location was the head–neck. Other benign soft tissue tumors were neurofibroma (8.8%), lipoma (6.1%), schwannoma (5.1%), and neuroma (4.4%). Rhabdomyosarcoma (53.2%) was the most common malignant soft tissue tumor. The embryonal subtype was the most common (36.6%). Other malignant soft tissue tumors were extra-osseous PNET/Ewing’s sarcoma (16.6%), synovial sarcoma (13.3%), and leiomyosarcoma (3.3%). Conclusion: Similar to the literature, in this study, the most common benign soft tissue tumor in children was hemangioma, and the most common malignant soft tissue tumor was rhabdomyosarcoma. It is hoped that this study will contribute to the literature as it is the first study to cover all childhood soft tissue tumors at national and regional scale.

PDF

___

1. The WHO Classification of Tumors editorial Board.
1.Soft Tissue Tumors. Antonescu CR, Bridge JA, Cunha IW et al. Soft Tissue and Bone Tumors. 5th Edition, Lyon: International Agency for Research on Cancer; 2020; p.1-12
2. Hayani A, Mahoney DH Jr, Hawkins HK, et al. Softtissue sarcomas other than rhabdomyosarcoma in children. Med Pediatr Oncol 1992;20:114-8.
3. Gurney JG, Severson RK, Davis S, at al: Incidence of cancer in children in the United States: Sex-, race- and 1-year age-specific rates by histologic type. Cancer 1995;75:2186-95.
4. Sultan I, Qaddoumi I, Yaser S, et al: Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: An analysis of 2,600 patients. J Clin Oncol 2009 27:3391-7.
5. Kutluk MT, Yeşilipek A. Turkish National Pediatric Cancer Registry 2002-2008 (Turkish Pediatric Oncology Group and Turkish Pediatric Hematology Society). J Clin Oncol 2013;31:15.
6. Bovee JV, Hogendoorn PC. Molecular pathology of sarcomas: concepts and clinical implications. Virchows Arch 2010;456:1939.
7. Frassica FJ, Thompson RC Jr: Evaluation, diagnosis, and classification of benign soft-tissue tumors. Instr Course Lect 1996;45:447-60.
8. Kucukodaci Z. Molecular features and diagnostic aproaches in soft tissue tumors. In: Dervişoğlu S. Soft tissue tumors. Ankara: Kongre Kitapevi; 2016; p. 49- 74.
9. Dervisoglu S. Chapter 1: Patological features spesific to childhood. In: Bone-soft tissue tumors- Editörler K. Engin, Y. Sağlık, U. Aydinli, Nobel Tıp Kitabevleri. Ankara. 2005;p. 562-99..
10. Dervisoglu S. Problems encountered in pathological evaulation. In: Dabak N. ed. Bone and soft tissue tumors with multidisciplinary approach. Ankara: TOTBID yayınları; 2013; p. 83-94.
11. Goldblum JR, Folpe AL, Weiss S. Chapter 1: General considerations. Enzinger and Weiss’s Soft Tissue Tumors, 6th ed. Philadelphia: Elsevier Saunders; 201;p. 1-10.
12. Bridge JA. The role of cytogenetics and molecular diagnostics in the diagnosis of soft-tissue tumors. Mod Pathol 2014;27:80-97.
13. O’Sullivan B, Wylie J, Catton C. The local management of soft tissue sarcomas. Semin Radiat Oncol 1999;9:328-48
14. Suit HD, Spiro I. Role of radiation in the management of adult patients with sarcoma of soft tissue. Semin Surg Oncol. 1994;10:347-56.
15. Suit HD, Mankin HJ, Wood WC, et al. Treatment of the patient with stage M0 soft sarcoma. J Clin Oncol 1988;60:854-62.
16. Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol 1995;164:129-34.
17. Patel Y. M, Tandel H. K. Histopathological differentiation and incidence of soft tissue tumors: study of 140 cases. Trop J Path Micro 2017;3:335-9.
18. Visalakshi S, Rani NL, Shanthi B, et al. V. Soft Tissue Neoplasms: Distribution and Diagnostic Strategies Including Immunohistochemical Study. Int J Sci Stud 2016;4:29-34.
19. Dabak N, Cirakli A, Gulman B, et al. Distribution and evaluation of bone and soft tissue tumors in the middle Black Sea Region. Acta Orthop Traumatol Turc 2014;48:17-24.
20. Shidham VB, Acker SM, Vesole DH, at all. Benign and malignant soft tissue tumors, In. Orthopedic Surgery, eMedicine from WebMD. Updated Dec 12, 2006.
21. Sevimli R. Distribution and evaluation of primary bone and soft tissue tumors admitted from Malatya province and surrounding provinces. Med Science 2017;6:546-50
22. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69:412-22.
23. Aflatoon K. Pediatric Soft-Tissue Tumors J Am Acad Orthop Surg 2003;11:332-43.
24. Coffin CM, Alaggio R. Adipose and myxoid tumors of childhood and adolescence. Pediatr Dev Pathol. 2012;15:239-54.
25. Ognjanovic S, Linabery AM, Charbonneau B, et al. Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005. Cancer. 2009;115:4218-26.
26. Kachanov DY, Dobrenkov KV, Abdullaev RT, et al. Incidence and survival of pediatric soft tissue sarcomas in moscow region, Russian Federation, 2000-2009. Sarcoma. 2012;2012:350806.
27. Dasgupta, R. Fuchs, J. Rodeberg, D. Rhabdomyosarcoma. Semin. Pediatr. Surg. 2016;25:276-83.
28. Bilgic B. Skeletal muscle tumors. In: Dervisoglu S. Soft tissue tumors. Ankara: Kongre Kitapevi; 2016 p. 331- 45.